Navigation auf


UZH Innovation Hub

UZH spin-off Recolony idolized in 20 minutes

Ana Montalban
Photo: Egle Katkeviciute, Ana Montalban-Arques and Philipp Busenhart (from left to right)


UZH molecular biologist and entrepreneur Ana Montalban-Arques has set herself an ambitious goal: she wants to beat cancer with intestinal bacteria - preferably without side effects. The head of the Zurich biotech start-up Recolony is researching a cancer therapy that is already causing a sensation internationally. Now her story is portrayed in 20 min.  


Ana Montalban-Arques was previously funded for her innovative therapy with a UZH Entrepreneur Fellowship and an SNF BRIDGE Grant. Recolony was accepted into the WyssZurich Accelerator in spring 2022.


Innovation Hub

Weiterführende Informationen


Bacteria-based cancer therapy